Vera Therapeutics: FDA's eGFR Analysis Supports A Speculative Buy (NASDAQ:VERA)

· seekingalpha.com

Vera Therapeutics is upgraded to Buy following TRUTAKNA's FDA approval and encouraging eGFR data. Learn more about VERA stock here.

About the TPT service

Thanks for reading. At the Total Pharma Tracker, we offer most of the following:-

For investors requiring hands-on support, our in-hou...


More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI